Theranostics Market, till 2035 - Distribution by Type of Product (Diagnostic Imaging (MRI, PET Imaging, Nuclear Imaging, CT Scan, Molecular Imaging and Other Diagnostic Imaging), Radiopharmaceuticals (Lutetium-177, Samarium-153, Radium-223, Iodine-131, Yttrium-90, Gallium-68, Fluorine-18 and Other Radiopharmaceuticals), IVD / Biomarker Screening (Polymerase Chain Reaction, Next-Generation Sequencing and Fluorescence In-Situ Hybridization) and Software and Services), Application Area (Prostate Cancer, Bone Metastasis, Neuroendocrine Tumors, Lymphoma, Cardiovascular Diseases and Other Applications), End User (Hospitals, Diagnostics Centers, Specialty Clinics and Other End Users), Key Geographical Regions and Leading Players: Industry Trends and Global Forecasts